GLP-1
Liraglutide
Liraglutide is a once-daily GLP-1 receptor agonist used in type 2 diabetes and weight management. BOOKPHARM supplies liraglutide as an active ingredient and supports injectable finished-dosage manufacturing.
Supply offerings
| Business line | Business model | Regulatory status |
|---|---|---|
| FDFGLP-1 | API + FDF CMO/Supply | Approval in US |
| APIGLP-1 | API supply | NDC+US DMF |
Supplied for pharmaceutical manufacturing and R&D by licensed and qualified entities. Not for human use as supplied. Availability is subject to regulatory approval in the buyer's jurisdiction.